UBS AM’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
UBS AM's STIM Position: Q3 2026 in Review
UBS AM opened a new position in Neuronetics (STIM) in Q3 2026: 24 shares worth $56. The stake represents ﹤0.01% of the portfolio and ranks #4235 among its holdings.
71 funds tracked by Wall St. Rank hold STIM as of Q3 2026.
- UBS AM held 24 shares of Neuronetics worth $56 as of Q3 2026.
- Neuronetics was a new UBS AM position in Q3 2026.
- Neuronetics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4235 holding.
- 71 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.